Monosomal karyotype in adult acute myeloid leukemia: Prognostic impact and outcome after different treatment strategies

Blood

Volumn 119, Issue 2, 2012, Pages 551-558

  Kayser, Sabine ^a   Zucknick, Manuela ^b   Döhner, Konstanze ^a   Krauter, Jürgen ^c   Köhne, Claus Henning ^d   Horst, Heinz A ^e   Held, Gerhard ^f   Von Lilienfeld Toal, Marie ^g   Wilhelm, Sibylla ^h   Rummel, Mathias ⁱ   Germing, Ulrich ^j   Götze, Katharina ^k   Nachbaur, David ^l   Schlegelberger, Brigitte ^c   Göhring, Gudrun ^c   Späth, Daniela ^a   Morlok, Carina ^a   Teleanu, Veronica ^a   Ganser, Arnold ^c   Döhner, Hartmut ^a   Schlenk, Richard F ^a   more..

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d KLINIKUM OLDENBURG   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

ⁱ UNIVERSITY HOSPITAL GIESSEN   (Germany)

^j HEINRICH HEINE UNIVERSITY   (Germany)

^k UNIVERSITY OF MUNICH   (Germany)

^l UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; NUCLEOPHOSMIN; PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL; CHROMOSOME ABERRATION; CYTOGENETICS; FEMALE; GENE DUPLICATION; GENE MUTATION; HUMAN; KARYOTYPE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MONOSOMAL KARYOTYPE; MONOSOMY; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84855857727     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-367508     Document Type: Article

References (25)

1. Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev. 2004;18(2): 115-136. (Pubitemid 38380667)
2. Schlenk RF, Ganser A, Döhner K. Prognostic and predictive effect of molecular and cytogenetic aberrations in acute myeloid leukemia. ASCO Educational Book. 2010;228-232.
3. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. 4th ed. Geneva, Switzerland: WHO Press; 2008.
4. Schlenk RF, Döhner K. Impact of new prognostic markers in treatment decisions in acute myeloid leukemia. Curr Opin Hematol. 2009;16(2): 98-104.
5. Marcucci G, Haferlach T, Döhner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol. 2011;29(5):475-486.
6. Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
7. Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol. 2008;26(29):4791-4797.
8. Schlenk RF, Benner A, Hartmann F, et al. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Leukemia. 2003;17(8): 1521-1528. (Pubitemid 36986953)
9. Schlenk RF, Germing U, Hartmann F, et al. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia. 2005;19(6):978-983. (Pubitemid 40862008)
10. Schlenk RF, Döhner K, Mack S, et al. Prospective evaluation of allogeneic hematopoietic stem cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: Results of German-Austrian AMLSG treatment trialAMLHD98A. J Clin Oncol. 2010;28(30):4642-4648.
11. Schlenk RF, Fröhling S, Hartmann F, et al. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia. 2004;18(11):1798- 1803.
12. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French- American-British Cooperative Group. Ann Intern Med. 1985;103(4):620-625.
13. Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon, France: IARC Press, 2001.
14. Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 1995.
15. Schlenk RF, Döhner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukaemia. N Engl J Med. 2008; 358(18):1909-1918. (Pubitemid 351620111)
16. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003; 21(24):4642-4649. (Pubitemid 46594039)
17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-481.
18. Mantel N, Byar D. Evaluation of response-time data involving transient states: An illustration using heart transplant data. J Am Stat Assoc. 1974; 69:81-86.
19. Cox DR. Regression models and life tables (with discussion). J R Stat Soc. 1972;34(2):187-220.
20. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer Verlag; 2001.
21. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
22. Medeiros BC, Othus M, Fang M, et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood. 2010;116(13):2224-2228.
23. Lugthart S, Gröschel S, Beverloo HB, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21; q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010; 28(24):3890-3898.
24. Fang M, Storer B, Estey E, et al. Outcome of acute myeloid leukemia patients with monosomal karyotype who undergo hematopoietic cell transplantation. Blood. 2011;118(6):1490-1494.
25. Oran B, Dolan M, Cao Q, et al. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia. Biol Blood Marrow Transplant. 2011;17(3):356-364.